Integral Diagnostics Limited (ASX:IDX)
2.330
0.00 (0.00%)
Aug 27, 2026, 4:10 PM AEST
Integral Diagnostics Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Integral Diagnostics stock has a consensus rating of "Buy" and an average price target of $3.01. The average 1-year stock price forecast is 29.18% higher than the current stock price, while the lowest is $2.24 (-3.86%) and the highest is $3.70 (+58.80%).
Price Target: $3.01 (+29.18%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Integral Diagnostics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 8 | 8 | 8 | 8 | 9 |
| Buy | 3 | 3 | 3 | 4 | 4 | 4 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Total | 13 | 12 | 12 | 13 | 13 | 14 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jarden | Jarden | Buy Maintains $2.95 | Buy | Maintains | $2.95 | +26.61% | Aug 27, 2026 |
| Jefferies | Jefferies | Buy Maintains $3.50 → $3.30 | Buy | Maintains | $3.50 → $3.30 | +41.63% | Aug 27, 2026 |
| Bell Potter | Bell Potter | Buy Maintains $3.60 → $3.15 | Buy | Maintains | $3.60 → $3.15 | +35.19% | Aug 26, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $3.50 | Buy | Maintains | $3.50 | +50.21% | Aug 26, 2026 |
| Ord Minnett | Ord Minnett | Buy Maintains $3.20 → $3.30 | Buy | Maintains | $3.20 → $3.30 | +41.63% | Aug 26, 2026 |
Financial Forecast
Revenue This Year
837.72M
from 788.62M
Increased by 6.23%
Revenue Next Year
888.84M
from 837.72M
Increased by 6.10%
EPS This Year
0.13
from 0.13
Increased by 6.32%
EPS Next Year
0.16
from 0.13
Increased by 17.97%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.